Justin Petrone covers consumer genomics, ancestry testing, and the microarray and biochip sector of the genomics market for GenomeWeb.
The test is the cornerstone of a study involving roughly a thousand patients from two British neonatal centers that is set to commence this fall.
The firm is reassuring participants that their data is secure following media coverage highlighting GMI's position as a fully-owned subsidiary of WuXi NextCode.
The new partnership will support the analysis of glycans in 30,000 human samples by the end of 2021.
The new initiative, called MEGA+, will extend the process of genomic data sharing to all medical data, including electronic health records and imaging files.
Patients who enroll will have their samples tested as part of routine diagnostic care, making it easier for them to take part in clinical trials without additional testing.
The Genes for Good Project has engaged 80,000 Facebook users via its online application and genotyped 27,000 people to date.
NatGeo will continue to conduct research using its database, which includes data on roughly a million individuals.
The Israeli online genealogy company recently expanded its ancestry genetic testing offering to include health information.
The test relies on a signature that Almac developed for stratifying breast cancer patients, but which, as the researchers showed, can be used in other cancers as well.
Consumer genomics companies have endeavored to reach out to minority communities with sometimes contentious results.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.